You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Haven't imposed any export ban on Covaxin, Covishield, says govt

Global vaccine alliance Gavi, which runs the Covax programme, said that Indian vaccine supplies to lower income countries are being delayed

Topics
Coronavirus | Coronavirus Tests | Coronavirus Vaccine

BS Web Team  |  New Delhi 

Arindam Bagchi
Photo: ANI

The ministry of external affairs on Friday clarified that India has not imposed any export ban on vaccines and the government has supplied jabs to more than 80 countries across the world.

"No country has shared with the world the number of vaccines that India has while vaccinating its own population. Till now, we have supplied vaccines to more than 80 countries across in the world and we have already stated that our external supplies would be done keeping in mind our domestic requirements," Arindam Bagchi, spokesperson for MEA said.

"A total of 64.4 million doses of vaccine supplied to various countries and 18.2 million through covax so far," the MEA spokesperson said.

Reuters reported that India has put a temporary hold on all major exports of the AstraZeneca shot made by the Serum to meet domestic demand as infections continue to rise.

There have been concerns that other developing nations depending upon Serum Institute's contract with the vaccine alliances for their doses will struggle to continue their roll-outs.

The Serum Insitute was due to deliver 90 million vaccine doses to Covax over March and April and, while it was not immediately clear how many would be diverted for domestic use.

Global vaccine alliance Gavi, which runs the Covax programme, said that Indian vaccine supplies to lower income countries are being delayed.

"Deliveries will be delayed in March and April as the government of India battles a new wave of Covid-19 infections," it said in a statement.

Regarding the concerns of other countries, India's position has been suitably conveyed through its official channels, the MEA spokesperson said.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, April 02 2021. 16:54 IST
RECOMMENDED FOR YOU